Rac Regulates Thrombin-Induced Tissue Factor Expression in Pulmonary Artery Smooth Muscle Cells Involving the Nuclear Factor-κB Pathway
- 1 August 2004
- journal article
- research article
- Published by Mary Ann Liebert Inc in Antioxidants and Redox Signaling
- Vol. 6 (4) , 713-720
- https://doi.org/10.1089/1523086041361703
Abstract
Pulmonary hypertension is associated with enhanced thrombogenicity of the vessel wall contributing to vascular remodeling. However, the signaling mechanisms promoting this prothrombotic state are not resolved. Here we investigated the role of the GTPase Rac in the regulation of tissue factor (TF) expression and activity in response to thrombin in pulmonary artery smooth muscle cells (PASMC). TF mRNA and protein expression and surface procoagulant activity were increased by thrombin in PASMC. These responses were enhanced in the presence of the constitutively active Rac mutant RacG12V, but were abrogated in cells expressing dominant-negative RacT17N. Thrombin and RacG12V also increased human TF promoter activity primarily involving a sequence between -636 and -111 bp containing a distal, nuclear factor-κB (NFκB)-dependent enhancer element. Indeed, thrombin and RacG12V stimulated NFκB-dependent transcriptional activity, and overexpression of p50/p65 significantly increased human TF promoter activity. Moreover, in RacG12V-overexpressing cells, TF promoter activity was significantly decreased by coexpression of dominant-negative mutants of IκBα and IκBKα, which prevent NFκB activation. As enhanced NFκB activity has been observed in patients with pulmonary hypertension, Rac-dependent activation of the NFκB pathway may be a critical element promoting thrombin-induced TF expression and activity, and thus a prothrombotic state in pulmonary hypertension.Keywords
This publication has 29 references indexed in Scilit:
- Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal modelArthritis & Rheumatism, 2003
- Regulation of gene expression by oxygen: NF-κB and HIF-1, two extremesPublished by Elsevier ,2002
- Statin Prevents Tissue Factor Expression in Human Endothelial CellsCirculation, 2002
- Oxidative stress and expression of p22phox are involved in the up-regulation of tissue factor in vascular smooth muscle cells in response to activated plateletsThe FASEB Journal, 2000
- Lipopolysaccharide-induced Tumor Necrosis Factor-α Promoter Activity Is Inhibitor of Nuclear Factor-κB Kinase-dependentPublished by Elsevier ,1999
- Lipopolysaccharide Induction of Tissue Factor in THP-1 Cells Involves Jun Protein Phosphorylation and Nuclear Factor κB Nuclear TranslocationJournal of Biological Chemistry, 1999
- Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins.Genes & Development, 1997
- Mechanism of the Tumor Necrosis Factor α-mediated Induction of Endothelial Tissue FactorPublished by Elsevier ,1995
- Transcriptional Regulation of Tissue Factor Expression in Human Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation.Journal of Clinical Investigation, 1993